Ledger.Open graph →
SEC Form D · Amendment · filed August 13, 2018

Aclaris Therapeutics, Inc

Offering
$12.5M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WAYNE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Christopher Powala · MALVERN, PAExecWilliam A. Humphries · Wayne, PADirectorAnand A. Mehra · Malvern, PADirectorMatt Auriemma · Grand Cayman, Cayman IslandsDirectorBrett A. Fair · Wayne, PAExecBenjamin S. Miller · WASHINGTON, Washington, D.C.DirectorNeal Walker · Wayne, PAExec · DirectorAndrew A. Schiff · Wayne, PADirectorBryan A. Reasons · Wayne, PADirectorFrank Ruffo · MALVERN, PAExecAndrew A. Powell · Wayne, PADirectorStuart Shanler · MALVERN, PAExecChristopher Powala · Wayne, PAExecKamil Ali-Jackson · Malvern, PAExecChristopher A. Molineaux · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗